Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-01

Clinical Trial Update: Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a randomized study in Parkinson's disease using pluripotent adipose stem cells (PASCs) in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pluripotent adipose stem cells (PASCs)

Snippet

Sponsor: ClusterXStem-Costa Rica | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: UNKNOWN